Presentation is loading. Please wait.

Presentation is loading. Please wait.

Antidepressant Therapy in Patients Undergoing Coronary Artery Bypass Grafting: The MOTIV-CABG Trial  Sidney Chocron, MD, PhD, Pierre Vandel, MD, PhD,

Published byTorje Iversen Modified over 6 years ago

Similar presentations

Presentation on theme: "Antidepressant Therapy in Patients Undergoing Coronary Artery Bypass Grafting: The MOTIV-CABG Trial  Sidney Chocron, MD, PhD, Pierre Vandel, MD, PhD,"— Presentation transcript:

1 Antidepressant Therapy in Patients Undergoing Coronary Artery Bypass Grafting: The MOTIV-CABG Trial 
Sidney Chocron, MD, PhD, Pierre Vandel, MD, PhD, Camille Durst, MD, Frédéric Laluc, MD, Djamel Kaili, MD, Michael Chocron, PhD, Joseph-Philippe Etievent, MD  The Annals of Thoracic Surgery  Volume 95, Issue 5, Pages (May 2013) DOI: /j.athoracsur Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Study flowchart by treatment group. (BDI = Beck Depression Inventory Short Form; ITT = intention-to-treat.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Change from baseline in Beck Depression Inventory (BDI) score by period (1, 3, and 6 months) and treatment group. (A) Treated cohort; (B) Patients with a preoperative BDI > 3. Values presented are adjusted mean change in score from baseline from a repeated measure analysis of covariance on changes in scores with treatment and visit as factors, treatment by visit interaction, and baseline score as covariate. A negative change shows an improvement. Error bars indicate standard errors. (∗ indicates p values < 0.05 for treatment-group difference; ▴ = placebo; • = escitalopram.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Change from baseline in Short Form (SF)-36 Physical Component Summary (PCS) score by period (1, 3, and 6 months) and treatment group; (A) Treated cohort; (B) Patients with a preoperative Beck Depression Inventory > 3. Values presented are adjusted mean change in score from baseline from a repeated measure analysis of covariance on changes in scores with treatment and visit as factors, treatment by visit interaction, and baseline score as covariate. A positive change shows an improvement. Error bars indicate standard errors. (∗ indicates p values < 0.05 for treatment-group difference; ▴ = placebo; • = escitalopram.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Change from baseline in Short form (SF)-36 Mental Component Summary (MCS) score by period (1, 3, and 6 months) and treatment group; (A) treated cohort and (B) patients with a preoperative Beck Depression Inventory > 3. Values presented are adjusted mean change in score from baseline from a repeated measure analysis of covariance on changes in scores with treatment and visit as factors, treatment by visit interaction and baseline score as covariate. A positive change shows an improvement. Error bars indicate standard errors. (∗ indicates p values < 0.05 for treatment-group difference; ▴ = placebo; • = escitalopram.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

6 Fig 5 Change from baseline in Short Form (SF)-36 domain scores by period (1, 3, and 6 months) and treatment group; (A) treated cohort and (B) patients with a preoperative Beck Depression Inventory > 3. Values presented are adjusted mean change in score from baseline from a repeated measure analysis of covariance on changes in scores with treatment and visit as factors, treatment by visit interaction, and baseline score as covariate. A positive change shows an improvement. Error bars indicate standard errors. (∗ indicates p values < 0.05 and ∗∗ indicates p values < 0.01 for treatment-group difference.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Antidepressant Therapy in Patients Undergoing Coronary Artery Bypass Grafting: The MOTIV-CABG Trial  Sidney Chocron, MD, PhD, Pierre Vandel, MD, PhD,"

Similar presentations

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Peter K. Smith, MD, Robert M. Califf, MD, Robert H
Assessment of the Association of Bilateral Internal Thoracic Artery Skeletonization and Sternal Wound Infection After Coronary Artery Bypass Grafting 

Assessment of the Association of Bilateral Internal Thoracic Artery Skeletonization and Sternal Wound Infection After Coronary Artery Bypass Grafting 
Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,
Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,
Is Hospital Procedure Volume a Reliable Marker of Quality for Coronary Artery Bypass Surgery? A Comparison of Risk and Propensity Adjusted Operative and.

Is Hospital Procedure Volume a Reliable Marker of Quality for Coronary Artery Bypass Surgery? A Comparison of Risk and Propensity Adjusted Operative and.
Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,
Manuel Caceres, MD, Darryl S. Weiman, MD, JD 

Manuel Caceres, MD, Darryl S. Weiman, MD, JD 
Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction  Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.

Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction  Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.
Preoperative Prophylactic Intraaortic Balloon Pump Reduces the Incidence of Postoperative Acute Kidney Injury and Short-Term Death of High-Risk Patients.

Preoperative Prophylactic Intraaortic Balloon Pump Reduces the Incidence of Postoperative Acute Kidney Injury and Short-Term Death of High-Risk Patients.
Petar M. Vuković, MD, Sandra S. Radak, MD, Miodrag S

Petar M. Vuković, MD, Sandra S. Radak, MD, Miodrag S
Preoperative Aspirin Use and Its Effect on Adverse Events in Patients Undergoing Cardiac Operations  Jiapeng Huang, MD, PhD, Macarius Donneyong, PhD,

Preoperative Aspirin Use and Its Effect on Adverse Events in Patients Undergoing Cardiac Operations  Jiapeng Huang, MD, PhD, Macarius Donneyong, PhD,
A. Laurie W. Shroyer, PhD, Brack Hattler, MD, Todd H

A. Laurie W. Shroyer, PhD, Brack Hattler, MD, Todd H
Randomized controlled trial of brief cognitive behavioral intervention for depression and anxiety symptoms preoperatively in patients undergoing coronary.

Randomized controlled trial of brief cognitive behavioral intervention for depression and anxiety symptoms preoperatively in patients undergoing coronary.
Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery  Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,

Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery  Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,
Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.
Aleksander Zywot, MD, MPH, Christine S. M

Aleksander Zywot, MD, MPH, Christine S. M
Coronary Bypass Grafting to a “Full-Metal Jacket” Left Anterior Descending Artery  María J. Mataró, MD, Gemma Sánchez-Espín, MD, Carlos Porras, MD, José.

Coronary Bypass Grafting to a “Full-Metal Jacket” Left Anterior Descending Artery  María J. Mataró, MD, Gemma Sánchez-Espín, MD, Carlos Porras, MD, José.
The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery  Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.

The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery  Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.
Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,
The Society of Thoracic Surgeons Thoracic Surgery Practice and Access Task Force: 2014 Workforce Report  John S. Ikonomidis, MD, PhD  The Annals of Thoracic.

The Society of Thoracic Surgeons Thoracic Surgery Practice and Access Task Force: 2014 Workforce Report  John S. Ikonomidis, MD, PhD  The Annals of Thoracic.

Similar presentations

Ads by Google